Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Related Research Data
Second generation of primaquine ureas and bis-ureas as potential antimycobacterial agents
Source:
Springer Science and Business Media LLC
Primaquine-Induced Hemolytic Anemia: Role of Membrane Lipid Peroxidation and Cytoskeletal Protein Alterations in the Hemotoxicity of 5-Hydroxyprimaquine
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Giving structure to the biofilm matrix: an overview of individual strategies and emerging common themes
Source:
Oxford University Press (OUP)
5-Lipoxygenase inhibitors: a review of recent developments and patents
Source:
Informa Healthcare
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Source:
American Society for Microbiology
Urea and carbamate derivatives of primaquine: synthesis, cytostatic and antioxidant activities.
Source:
Elsevier BV
Primaquine revisited six decades after its discovery.
Source:
Elsevier BV
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms
Source:
Elsevier BV
Primaquine hybrids as promising antimycobacterial and antimalarial agents.
Source:
Elsevier BV
The antimalarial drug primaquine targets Fe-S cluster proteins and yeast respiratory growth.
Source:
HAL CCSD
Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine − synthesis, cytostatic, antiviral and antioxidative studies
Source:
Informa UK Limited
Effects of the antimalarial drug primaquine on the dynamic structure of lipid model membranes.
Source:
Elsevier B.V.
The role of bacterial biofilms in chronic infections
Source:
Wiley
Agents that inhibit bacterial biofilm formation
Source:
Future Science Ltd
Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors.
Source:
Molecular Diversity Preservation International (MDPI)
Linking provided by
